- Frankel, Arthur E;
- Reddy, Renuka;
- DeSuza, Kayla R;
- Deeb, Khaled;
- Carlin, Aaron F;
- Smith, Davey;
- Xie, Yushuang;
- Naik, Eknath;
- Silver, Richard T;
- Hasselbalch, Hans C
An 83-year-old female had asymptomatic SARS-CoV-2 infection while taking ruxolitinib. She remained RT-PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID-19.
